January 2026

Any comments/suggestions please email the editor at editor@redrockrx.com

Edited by Malcolm Fraser MD, CMD


Looking Ahead: 2026 Compliance Priorities

First of all, I hope you all had a wonderful holiday break and were able to spend time with friends and family. Here at Red Rock Pharmacy, we were very busy. One thing I always worry about over the holidays is weather-related service issues. Luckily, the weather was mild over the holiday season, and we did not encounter any problems.


So, what will be our focus in 2026?

  • One thing we are already seeing is increased surveyor vigilance concerning the F605 Tag related to PRN psych medication documentation issues. As mentioned last month, a single lapse in documentation can result in the F605 Tag being cited and the dreaded Red Hand appearing on the CMS website.
  • We anticipate that many of the nursing homes we serve will want to become “PRN psych med–free,” and we look forward to supporting them in this important initiative. This will significantly reduce potential survey liability. For more details, please contact your Red Rock Consultant Pharmacist.
    

Another item we are closely monitoring is the Colorado Health Department Chapter 5 rewrite (the statute that governs nursing homes in Colorado), which is expected to be completed by mid-summer 2026. We anticipate that other western states we serve may follow Colorado’s lead and will keep you updated accordingly.


Shixian Wang

Director of Operations



New Year, New Insurance Formularies

Most insurance plans update their formularies at least once each year, with changes typically taking effect on January 1. When an insurance company updates its formulary, it may add new medications to the covered list, remove medications that were covered in the prior year, change which drugs are considered “preferred,” move medications to different cost tiers, or add or remove prior authorization or step therapy requirements.



The tier system generally ranges from Tier 1 (generic, low cost) to Tier 5 (specialty, very high cost), with out-of-pocket costs increasing as the tier level rises.


Even if a resident’s insurance plan remains the same, medication coverage can change due to these updates. Insurance companies review formularies to account for newly FDA-approved medications, promote lower-cost or generic alternatives, adjust coverage based on utilization and safety data, and align with negotiated pricing agreements.


While these changes can help control costs, they can also affect medication access if not identified early. New formularies may result in increased scrutiny of medications and additional steps required to obtain insurance approval for refills.


In the long-term care setting, this can lead to delayed refills when new approvals are required. It may also cause unexpected medication changes, increased out-of-pocket costs, and additional administrative work for healthcare teams.



Red Rock Pharmacy regularly monitors formulary updates and helps identify medications affected by coverage changes. When appropriate, we recommend covered alternatives and coordinate prior authorizations with prescribers to help keep medication delivery consistent and uninterrupted.


Understanding formulary updates early in the year helps reduce surprises and supports smoother medication management throughout the year. One helpful strategy as we enter the new year is to begin ordering medications a few days earlier. This allows time to identify formulary changes and work through insurance requirements so residents do not miss any doses.


We remain committed to providing the highest level of service and delivery throughout these ongoing changes. Together, we will adapt and move forward successfully into the new year.


Dave Rimlinger

Director of Marketing



Here’s what we at Red Rock Pharmacy believe nursing homes should focus on in 2026:


Master the Revised Surveyor Guidance

Ensure ongoing compliance with Appendix PP expectations—especially in nursing services, resident assessment, psychotropic use, and QAPI. 
Centers for Medicare & Medicaid Services



Align Quality Improvement (QI) Plans with New Measures

Proactively address quality measures that now drive Care Compare results, including claims-based antipsychotic use indicators. 
Centers for Medicare & Medicaid Services


Monitor Care Compare Impacts

Anticipate potential shifts in star ratings and public reporting, and prepare communication plans and internal reviews. 
AHCA/NCAL


Focus on Workforce Quality

Staffing patterns, documentation, and training will remain key compliance areas under survey review. 
Centers for Medicare & Medicaid Services


Adapt to Risk-Based Survey Approaches

Risk stratification will influence survey intensity—maintain strong compliance to minimize survey burden and reduce the risk of negative findings. 

AHCA/NCAL


2025-26 Flu Season Update


The dominant strain this flu season is the so-called “K” strain. So, what is the “K” strain?


The “K” strain refers to a genetically distinct subgroup of the influenza A (H3N2) virus, officially called H3N2 subclade K by global flu surveillance networks. It is a seasonal flu strain, not a new pandemic virus.


Subclade K has spread widely across the U.S. this season, and some reports have referred to it as a “super flu.” It has been described as highly contagious and is driving elevated flu activity in many states. Current estimates suggest that the flu vaccine offers some protection, particularly against severe outcomes. Children and older adults are among the groups most affected.

World Health Organization


Another type of Dementia that is frequently overlooked


Have your ever had a resident in a Nursing Home or Assisted Living Facility where the resident has Alzheimer’s but does not respond as expected to medicines? Well maybe they don’t have Alzheimer’s but have LATE.


LATE dementia refers to Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) — a common but under-recognized cause of dementia in very old adults, often mistaken for Alzheimer’s disease.


What is LATE?

• A neurodegenerative disease caused by abnormal accumulation of TDP-43 
 protein
 in the brain

• Primarily affects limbic structures (hippocampus, amygdala, frontal regions)

• Strongly age-associated — prevalence rises sharply after age 80


How LATE differs from Alzheimer’s:

Many patients have mixed pathology — LATE plus Alzheimer’s — which often leads to faster decline.


Diagnosis (current reality)

No definitive test while alive (no validated blood, CSF, or PET biomarker yet)

  Suspected when:

◦ Alzheimer’s-like dementia

◦ Over age 80

◦ Not responding as expected to psych medicines 


Treatment

• No disease-specific therapy

• Managed like other dementias:

◦ Cognitive support

◦ Safety planning

◦ Caregiver support

• Cholinesterase inhibitors and memantine may be tried, but evidence is limited 
 for LATE specifically


Why LATE matters

 Likely accounts for 15–25% of dementias in people over 85

• Explains why some patients diagnosed with “Alzheimer’s”:

◦ Don’t fit typical biomarker patterns

◦ Respond poorly to Alzheimer-targeted drugs

• Important for future drug development and clinical trials


ChatGPT accessed 12/22/2025.

DID YOU KNOW?


Alzheimer’s Disease markers increase more rapidly in obese people suggesting that AD will progress more quickly in people with a higher BMI. So the question is will the weight loss meds (GLP-1 Meds such as Wegovy) slow the progression of Alzheimer’s? We will keep you updated.


Source link: Article


How Long Does the Respiratory Syncytial Virus (RSV) Vaccine Last?


Question:

How long does a single respiratory syncytial virus (RSV) vaccine dose protect against RSV illness?


Answer:

A study of over 280,000 U.S. veterans aged 60 years and older who received the RSV vaccine between September 2023 and March 2024 evaluated how long protection lasted. The effectiveness of a single RSV vaccine dose compared to no vaccination was as follows:


Reduction in Risk — Effectiveness of a Single RSV Vaccine Dose vs. No Vaccination

The study found that RSV vaccination was effective in preventing RSV illness and reducing associated health care use; however, protection decreased over two RSV seasons.


As a result, various public health authorities are currently evaluating potential booster vaccination strategies. Red Rock Pharmacy will continue to monitor updates and keep our partners informed.


Source link:
Article

Nursing Home Staffing Rule Repealed

One of the most significant developments late last year was the rescission of the federal minimum staffing mandate for nursing homes:

  • The Centers for Medicare & Medicaid Services (CMS) issued an interim final rule in early December 2025, effective February 2, 2026, that removes the minimum staffing requirements finalized in 2024. Those requirements had mandated at least 3.48 hours of total nursing care per resident per day, including specific Registered Nurse (RN) and nurse aide hours, as well as a 24/7 onsite RN requirement. LeadingAge
  • The repeal essentially restores previous staffing standards, such as eight hours of RN coverage per day and a full-time Director of Nursing, and eliminates the newer numeric staffing minimums. Federal Register
  • CMS also announced plans to update the Nursing Home Care Compare online tool to improve the transparency and accuracy of facility performance data reported to the public. This announcement was among the most-read skilled nursing stories of 2025. Skilled Nursing News
  • The U.S. News Best Nursing Homes 2026 rankings found that fewer than one in five facilities earned top honors, with staffing shortages cited as a major factor in lower performance. 

Association of Health Care Journalists


If you have any questions, ask your Red Rock Consultant Pharmacist